About: Preliminary Analysis of the Impact of COVID‐19 Outbreak on Italian Liver Transplant Programs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Preliminary Analysis of the Impact of COVID‐19 Outbreak on Italian Liver Transplant Programs Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Preliminary Analysis of the Impact of COVID‐19 Outbreak on Italian Liver Transplant Programs
Creator	De Goyet, Ville De, Jean Di Benedetto, Fabrizio
Source	Medline; PMC
abstract	Liver Transplant Programs in Italy have faced a sequela of management and clinical decision‐making problems due to the high incidence in some regions of the country of severe acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2). The Italian Society for Organ Transplantation (SITO) and the Board of Liver Transplant Program Directors issued a survey to assess the initial impact of this pandemic event on the routine activity of 22 Italian Liver Transplant Programs. One hundred percent of participants completed the survey within a few days. The analysis is presented dividing the centers in two macro‐areas: north‐central Italy and south‐central Italy. The reason for this is that the two areas had a different incidence of the infection and because they have distinctive rates of cadaveric donation. Overall, all centers remained open although a reduction in the activity was noted. Transplant Programs reduced their outpatient activity both in terms of pre‐transplant evaluation (68% of the centers) and transplant recipient follow‐up (100%); a reduction in transplant activity was observed in the first two weeks of March only in the north‐central macro area (23 LTs vs 39 in 2018 and 60 in 2019); overall, SARS‐CoV‐2 infection was registered for 24 liver transplant recipients and 37 health care providers in liver transplant units. In the perspective of the increasing magnitude of the epidemic, more data will be required to define appropriate strategies for the increasingly complex management of liver transplant patients.
has issue date	2020-05-06(xsd:dateTime)
bibo:doi	10.1002/lt.25790
bibo:pmid	32378325
has license	no-cc
sha1sum (hex)	005ee8f68c1e67e2ca954e9241cd2947c1a42533
schema:url	https://doi.org/10.1002/lt.25790
resource representing a document's title	Preliminary Analysis of the Impact of COVID‐19 Outbreak on Italian Liver Transplant Programs
has PubMed Central identifier	PMC7267154
has PubMed identifier	32378325
schema:publication	Liver Transpl
resource representing a document's body	covid:005ee8f68c1e67e2ca954e9241cd2947c1a42533#body_text
is schema:about of	named entity 'Title' named entity 'PRELIMINARY' named entity 'TITLE' named entity 'Italian' named entity 'infection' named entity 'protected by copyright' named entity 'Liver Transplantation' named entity 'COVID-19' named entity 'intensive care units' named entity 'infection' named entity 'infection' named entity 'subject matter' named entity 'Italy' named entity 'Liver Transplant' named entity 'protected by copyright' named entity 'Liver Transplant' named entity 'Liver Transplant' named entity 'protected by copyright' named entity 'expert testimony' named entity 'exponentially increasing' named entity 'data analysis' named entity 'Data sharing' named entity 'Italian' named entity 'Italian' named entity 'epidemic' named entity 'informed consent' named entity 'Italy' named entity 'licensing arrangements' named entity 'oncologic' named entity 'COVID-19 Outbreak' named entity 'Liver Transplant' named entity 'Analysis' named entity 'Programs' named entity 'Impact' named entity 'Italian' named entity 'Transplant' named entity 'COVID-19' named entity 'ANALYSIS' named entity 'IMPACT' named entity 'ITALIAN' named entity 'OUTBREAK' named entity 'LIVER TRANSPLANT' named entity 'PROGRAMS'
is part of of	Liver Transplant Programs in Italy have faced a sequela of management and clinical decision‐making problems due to the high incidence in some regions of the country of severe acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2). The Italian Society for Organ Transplantation (SITO) and the Board of Liver Transplant Program Directors issued a survey to assess the initial impact of this pandemic event on the routine activity of 22 Italian Liver Transplant Programs. One hundred percent of participants completed the survey within a few days. The analysis is presented dividing the centers in two macro‐areas: north‐central Italy and south‐central Italy. The reason for this is that the two areas had a different incidence of the infection and because they have distinctive rates of cadaveric donation. Overall, all centers remained open although a reduction in the activity was noted. Transplant Programs reduced their outpatient activity both in terms of pre‐transplant evaluation (68% of the centers) and transplant recipient follow‐up (100%); a reduction in transplant activity was observed in the first two weeks of March only in the north‐central macro area (23 LTs vs 39 in 2018 and 60 in 2019); overall, SARS‐CoV‐2 infection was registered for 24 liver transplant recipients and 37 health care providers in liver transplant units. In the perspective of the increasing magnitude of the epidemic, more data will be required to define appropriate strategies for the increasingly complex management of liver transplant patients. covid:005ee8f68c1e67e2ca954e9241cd2947c1a42533#body_text Preliminary Analysis of the Impact of COVID‐19 Outbreak on Italian Liver Transplant Programs

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software